By combining in vivo and in vitro approaches, this work seeks to advance our understanding of the metabolic benefits of yerba mat and its potential as a nutraceutical intervention for obesity and T2DM
Just as GLP-1 therapies reshaped metabolic medicine, new hair-loss breakthroughs may reshape the future of scalp health and follicle regeneration
GLP-1 Companion Products Market At a Glance Key Growth Drivers, Constraints, and Opportunities Key Factors Driving Growth The soaring popularity of GLP-1 therapies for diabetes and obesity has led to a surge in demand for companion products to augment patient adherence and improve clinical outcomes
TML is then hydroxylated by 6-N-trimethyllysine dioxygenase (TMLD), which is located in the mitochondrial matrix, to form 3-hydroxy-6-N-trimethyllysine (HTML)
This role in the progressive phase deserves even more attention when considering that at this stage of the disease, BBB breakdown is less prominent and neurodegenerative processes are robust and driven by micro- and astroglia (97)
Satyanarayana T, Kunze G, editors
